- Recommendation ID
NICE encourages further research into low-energy contact X-ray brachytherapy (CXB) for early-stage rectal cancer. Research should clearly describe details of patient selection and treatment intent. It should document adjunctive treatments and subsequent procedures. Outcomes should include local recurrence, survival, disease-free survival and quality of life. NICE may update the guidance on publication of further evidence.
- Any explanatory notes
In patients for whom surgery is not considered suitable, current evidence on the efficacy and safety of low-energy contact X-ray brachytherapy (CXB; the Papillon technique) for early-stage rectal cancer is adequate to support the use of this procedure, provided that normal arrangements are in place for clinical governance, consent and audit.
Source guidance details
- Comes from guidance
- Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer
- Date issued
- September 2015
|Is this a recommendation for the use of a technology only in the context of research?||No|
|Is it a recommendation that suggests collection of data or the establishment of a register?||No|